|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 17.38 USD | -0.46% |
|
-3.71% | +47.79% |
| 08-27 | NeoGenomics Shares Rise After RaDaR ST Assay Gets Expanded Medicare Coverage | MT |
| 08-26 | NeoGenomics Wins Expanded Medicare Coverage for RaDaR ST Immunotherapy Monitoring | MT |
| Market Cap | 2.23B 1.92B 1.81B 1.65B 3.09B 211B 3.1B 21.36B 8.29B 108B 8.38B 8.2B 348B | P/E 2026 * |
-58.2x | P/E 2027 * | -71.1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.23B 1.92B 1.81B 1.65B 3.09B 211B 3.1B 21.36B 8.29B 108B 8.38B 8.2B 348B | EV / Sales 2026 * |
2.78x | EV / Sales 2027 * | 2.52x |
| Free-Float |
96.14% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NEO | Delayed | |
CBOE
| NEO | Real-time | |
|
Mexican S.E.
| NEO * | End-of-day quote | |
|
Tradegate
| NG9 | Real-time | |
|
Boerse Muenchen
| NG9 | Real-time | |
|
Deutsche Boerse AG
| NG9 | Delayed | |
|
Börse Stuttgart
| NG9 | Delayed | |
|
Berne S.E.
| NG9 | End-of-day quote |
Last Transcript : NeoGenomics, Inc.
| 1 day | -0.46% | ||
| 1 week | -3.71% | ||
| Current month | -2.96% | ||
| 1 month | +10.49% | ||
| 3 months | +59.45% | ||
| 6 months | +90.36% | ||
| Current year | +47.79% |
| 1 week | 16.86 |  | 18.18 |
| 1 month | 15.72 | | 19.76 |
| Current year | 7.06 | | 19.76 |
| 1 year | 7.06 | | 19.76 |
| 3 years | 4.72 | | 21.22 |
| 5 years | 4.72 | | 54.74 |
| 10 years | 4.72 | | 61.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anthony Zook
CEO | Chief Executive Officer | 65 | 2025-03-31 |
Abhishek Jain
DFI | Director of Finance/CFO | 57 | 2026-03-01 |
Warren Stone
PSD | President | 53 | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Lynn Tetrault
CHM | Chairman | 64 | 2021-10-06 |
Stephen Kanovsky
BRD | Director/Board Member | 63 | 2017-07-18 |
Michael Kelly
BRD | Director/Board Member | 69 | 2020-07-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Tax | General Counsel | -2,692 | 0.0021% | ||
| 8/21/26 | Exercice | Chairperson | 67,272 | 0.0524% | ||
| 8/4/26 | Sell | Controller/Auditor | -20,000 | 0.0156% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46% | -3.71% | +117.79% | +22.48% | 2.23B | |
| +0.16% | +0.59% | +95.32% | +452.21% | 47.31B | |
| -1.39% | -2.45% | +17.30% | +59.89% | 26.51B | |
| +1.24% | -2.50% | -14.82% | -39.67% | 6.96B | |
| -1.22% | -1.21% | +3.22% | +136.71% | 5.8B | |
| -2.48% | -2.78% | +15.55% | +70.23% | 3.32B | |
| -1.60% | -0.40% | -35.12% | +1,867.73% | 2.56B | |
| +7.98% | +6.89% | +27.90% | +40.95% | 2.14B | |
| +0.45% | -2.63% | -13.48% | -53.93% | 1.84B | |
| -0.82% | +2.80% | +34.86% | +201.66% | 1.63B | |
| Average | +0.19% | -0.69% | +24.85% | +275.83% | 10.03B | |
| Weighted average by Cap. | -0.24% | -0.46% | +51.84% | +287.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 804M 692M 651M 595M 1.11B 75.92B 1.12B 7.69B 2.99B 38.95B 3.02B 2.95B 125B | 885M 762M 717M 655M 1.22B 83.56B 1.23B 8.47B 3.29B 42.87B 3.32B 3.25B 138B |
| Net income | -39.05M -33.6M -31.62M -28.88M -54.03M -3.69B -54.18M -374M -145M -1.89B -147M -143M -6.09B | -32.73M -28.16M -26.5M -24.2M -45.28M -3.09B -45.4M -313M -121M -1.59B -123M -120M -5.11B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$17.38 | -0.46% | 997,013 |
| 26-09-03 | US$17.46 | +0.34% | 2,247,358 |
| 26-09-02 | US$17.40 | -0.29% | 1,794,476 |
| 26-09-01 | US$17.45 | -2.57% | 1,318,286 |
| 26-08-31 | US$17.91 | -0.78% | 1,579,101 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEO Stock
Select your edition
All financial news and data tailored to specific country editions
